Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (15,3 Mio. €): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast … Hor01.04.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank. How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.


Geförderte Unternehmen:

Firmenname Förderungssumme
ABBVIE Inc. 0,00 €
ACADEMISCH ZIEKENHUIS GRONINGEN 260.939 €
Agenzia Regionale Di Sanita 359.110 €
Alma Mater Studiorum - Universita Di Bologna 832.760 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 328.420 €
Bionotus 676.038 €
BRISTOL-MYERS SQUIBB COMPANY Corp. 0,00 €
Centre Hospitalier Universitaire de Toulouse 912.929 €
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS 482.806 €
Consiglio Nazionale Delle Ricerche 143.223 €
ELEVATE B.V. 114.919 €
Eli Lilly and Company Ltd. 0,00 €
Ellegaard Gottingen Minipigs AS 0,00 €
European Forum for Good Clinical Practice 71.648 €
European Institute of Women's Health CLG 135.160 €
Fundacion para El Fomento de La Investigacion Sanitaria y Biomedica de La Comunitat Valenciana 89.869 €
Glaxosmithkline Research & Development Ltd. 0,00 €
Hospices Civils de Lyon 0,00 €
Institut National de la Sante et de la Recherche Medicale 60.721 €
Izmir Katip Celebi Universitesi 0,00 €
Janssen Pharmaceutica N.V. 0,00 €
Karolinska Institutet 10.266,91 €
Katholieke Universiteit Leuven 1.062.746 €
Labcorp Early Development Laboratories Ltd. 0,00 €
Manchester University NHS Foundation Trust 0,00 €
Masarykova Univerzita 0,00 €
Medicines and Healthcare Products Regulatory Agency 60.597 €
Medizinische Universitat Graz 0,00 €
MERCK KGaA 0,00 €
MINISTRY OF HEALTH 0,00 €
Nearshore Macedonia Ltd. Skopje 0,00 €
NOVARTIS PHARMA AG 0,00 €
Novo Nordisk A/S 0,00 €
ORCION B.V. 235.314 €
Pfizer Ltd. 0,00 €
PNO Life Sciences & Health B.V. 41.638 €
Region Stockholm 89.000 €
Region Syddanmark 0,00 €
Region Uppsala 96.896 €
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU 107.321 €
Sanofi-Aventis Recherche & Developpement 0,00 €
SHAMIR HEALTH CORPORATION 0,00 €
Srebrnjak Children's Hospital 0,00 €
St George's Hospital Medical School 370.324 €
STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) Foundation 390.862 €
STICHTING LAREB 866.023 €
Swansea University 187.844 €
Synergist Services 0,00 €
Takeda Development Centre Europe Ltd. 0,00 €
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 0,00 €
TERVEYDEN JA HYVINVOINNIN LAITOS 283.161 €
TEVA PHARMACEUTICAL INDUSTRIES Ltd. 0,00 €
THE European Institute for Innovation Through Health Data 446.011 €
THE EUROPEAN MEDICINES AGENCY 33.158 €
The Newcastle Upon Tyne Hospitals NHS Foundation Trust 602.464 €
THE Synergist 316.464 €
The University of Manchester 390.398 €
UCB Biopharma 0,00 €
Universita Degli Studi Di Ferrara 238.532 €
UNIVERSITAET LEIPZIG 0,00 €
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 2.486.436 €
UNIVERSITE DE GENEVE 0,00 €
Universitetet I Oslo 806.665 €
University OF Kwazulu-Natal 122.638 €
University of Ulster 692.410 €
Uniwersytet Medyczny im Piastow Slaskich WE Wroclawiu 0,00 €
Uppsala Universitet 894.281 €

Quelle: https://cordis.europa.eu/project/id/821520

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.

Creative Commons Lizenzvertrag Die Visualisierungen zu "ABBVIE Inc. - EU-Förderung (15,3 Mio. €): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast …" werden von North Data zur Weiterverwendung unter einer Creative Commons Lizenz zur Verfügung gestellt.